These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 23888875)
1. Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes. Santoro M; Piacentini R; Masciullo M; Bianchi ML; Modoni A; Podda MV; Ricci E; Silvestri G; Grassi C Neuropathol Appl Neurobiol; 2014 Jun; 40(4):464-76. PubMed ID: 23888875 [TBL] [Abstract][Full Text] [Related]
2. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1. Kimura T; Nakamori M; Lueck JD; Pouliquin P; Aoike F; Fujimura H; Dirksen RT; Takahashi MP; Dulhunty AF; Sakoda S Hum Mol Genet; 2005 Aug; 14(15):2189-200. PubMed ID: 15972723 [TBL] [Abstract][Full Text] [Related]
3. Altered expression and splicing of Ca(2+) metabolism genes in myotonic dystrophies DM1 and DM2. Vihola A; Sirito M; Bachinski LL; Raheem O; Screen M; Suominen T; Krahe R; Udd B Neuropathol Appl Neurobiol; 2013 Jun; 39(4):390-405. PubMed ID: 22758909 [TBL] [Abstract][Full Text] [Related]
8. Characterization of sarcoplasmic reticulum Ca(2+) ATPase pumps in muscle of patients with myotonic dystrophy and with hypothyroid myopathy. Guglielmi V; Oosterhof A; Voermans NC; Cardani R; Molenaar JP; van Kuppevelt TH; Meola G; van Engelen BG; Tomelleri G; Vattemi G Neuromuscul Disord; 2016 Jun; 26(6):378-85. PubMed ID: 27133661 [TBL] [Abstract][Full Text] [Related]
9. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2). Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272 [TBL] [Abstract][Full Text] [Related]
10. Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2. Botta A; Vallo L; Rinaldi F; Bonifazi E; Amati F; Biancolella M; Gambardella S; Mancinelli E; Angelini C; Meola G; Novelli G Gene Expr; 2007; 13(6):339-51. PubMed ID: 17708420 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of CUGBP1 in skeletal muscle from adult classic myotonic dystrophy type 1 but not from myotonic dystrophy type 2. Cardani R; Bugiardini E; Renna LV; Rossi G; Colombo G; Valaperta R; Novelli G; Botta A; Meola G PLoS One; 2013; 8(12):e83777. PubMed ID: 24376746 [TBL] [Abstract][Full Text] [Related]
12. Ca2+-dependent excitation-contraction coupling triggered by the heterologous cardiac/brain DHPR beta2a-subunit in skeletal myotubes. Sheridan DC; Carbonneau L; Ahern CA; Nataraj P; Coronado R Biophys J; 2003 Dec; 85(6):3739-57. PubMed ID: 14645065 [TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2. Santoro M; Masciullo M; Bonvissuto D; Bianchi ML; Michetti F; Silvestri G Mol Cell Biochem; 2013 Aug; 380(1-2):259-65. PubMed ID: 23666741 [TBL] [Abstract][Full Text] [Related]
14. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds. Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1. Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322 [TBL] [Abstract][Full Text] [Related]
16. Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2). Salvatori S; Furlan S; Fanin M; Picard A; Pastorello E; Romeo V; Trevisan CP; Angelini C Neurol Sci; 2009 Jun; 30(3):185-92. PubMed ID: 19326042 [TBL] [Abstract][Full Text] [Related]
17. RyR1-mediated Ca2+ leak and Ca2+ entry determine resting intracellular Ca2+ in skeletal myotubes. Eltit JM; Yang T; Li H; Molinski TF; Pessah IN; Allen PD; Lopez JR J Biol Chem; 2010 Apr; 285(18):13781-7. PubMed ID: 20207743 [TBL] [Abstract][Full Text] [Related]
18. Functional impact of an oculopharyngeal muscular dystrophy mutation in PABPN1. García-Castañeda M; Vega AV; Rodríguez R; Montiel-Jaen MG; Cisneros B; Zarain-Herzberg A; Avila G J Physiol; 2017 Jul; 595(13):4167-4187. PubMed ID: 28303574 [TBL] [Abstract][Full Text] [Related]
19. Calcitonin gene-related peptide restores disrupted excitation-contraction coupling in myotubes expressing central core disease mutations in RyR1. Vega AV; Ramos-Mondragón R; Calderón-Rivera A; Zarain-Herzberg A; Avila G J Physiol; 2011 Oct; 589(Pt 19):4649-69. PubMed ID: 21825032 [TBL] [Abstract][Full Text] [Related]
20. Altered Ca2+ homeostasis and endoplasmic reticulum stress in myotonic dystrophy type 1 muscle cells. Botta A; Malena A; Loro E; Del Moro G; Suman M; Pantic B; Szabadkai G; Vergani L Genes (Basel); 2013 Jun; 4(2):275-92. PubMed ID: 24705164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]